Alyeska Investment Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.4M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $37M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $65.6M | Buy |
|
|||||
|
2022
Q2 | $51.9M | Buy |
|
|||||
|
2022
Q1 | $68.9M | Buy |
|
|||||
|
2021
Q4 | $71.7M | Buy |
|
|||||
|
2021
Q3 | $45.8M | Buy |
|
|||||
|
2021
Q2 | $22.6M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $14M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $60.6M | Buy |
|
|||||
|
2019
Q3 | $31.6M | Buy |
|
|||||
|
2019
Q2 | $20.7M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $23.1M | Sell |
|
|||||
|
2018
Q2 | $56.1M | Sell |
|
|||||
|
2018
Q1 | $65.9M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $58.2M | Sell |
|
|||||
|
2017
Q1 | $67.1M | Sell |
|
|||||
|
2016
Q4 | $64.5M | Buy |
|
|||||
|
2016
Q3 | $49.3M | Sell |
|
|||||
|
2016
Q2 | $49M | Buy |
|
|||||
|
2016
Q1 | $43.8M | Buy |
|
|||||
|
2015
Q4 | $2.65M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $19.1M | Sell |
|
|||||
|
2013
Q4 | $18.6M | Buy |
|
|||||
|
2013
Q3 | $13.9M | Buy |
|